DR.BABOON

What this record means

The record shows a live, pending application for the mark DR.BABOON owned by Niusaisi Guangzhou Biotechnology Co., Ltd., a limited company organized in China, and it is being examined for the Principal Register. The goods listed in class 005 are health‑food supplements, dietetic foods and beverages adapted for medical use, dietary supplements for humans and animals, dietetic animal foodstuffs for medical purposes, and nutritional supplements in forms such as capsules, tablets, powders, syrups, gummies and gels, with a stated first use in commerce on March 25, 2026. Because the application is still pending, the USPTO has approved it for publication but it has not yet been published for opposition, so the record does not give the owner control over every possible use of the words “DR BABOON” outside these specific supplement categories. The latest meaningful event is the examiner’s approval for publication on September 10, 2026; no enforcement actions, oppositions or cancellations appear in the supplied history. I'd treat this as a meaningful concern if you plan a similar name for any health‑related supplement or dietetic product, since that is the closest area of record‑based overlap.